eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2022
vol. 39
 
Share:
Share:
more
 
 
abstract:
Original paper

Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas

Aleksandra Iljin
1
,
Olga Stasikowska-Kanicka
2
,
Tomasz Zieliński
1
,
Anna Bąkiewicz
3
,
Stanisław Sporny
4
,
Ewa Woźniak-Roszkowska
5
,
Bogusław Antoszewski
1

1.
Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Lodz, Lodz, Poland
2.
Department of Diagnostic Techniques in Pathomorphology, Medical University of Lodz, Lodz, Poland
3.
Department of Pathology, Medical University of Lodz, Lodz, Poland
4.
Department of Pathomorphology, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
5.
Department of Plastic Surgery, Prof. Orłowski Memorial Hospital, Centre of Postgraduate Medical Education, Warsaw, Poland
Adv Dermatol Allergol 2022; XXXIX (5): 980-985
Online publish date: 2022/11/09
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Basal cell carcinoma (BCC) occurs in aggressive and non-aggressive forms. The expression of immunohistochemical markers varies in different types of BCC.

Aim
Immunohistochemical analysis of selected proteins in BCCs.

Material and methods
The immunohistochemical method was used to examine the immunoexpression of Bmi-1, CK15 and Bcl-2 in 56 cases of BCC divided into four groups. Results: Positive Bmi-1 staining 3–4+ level (nodular type) was seen in 91.3% of samples, 4+ (infiltrative) in 92.3%, 4+ (nodular/infiltrative) – 69.2%, 3+ – 30.8%, in BSC 3+ – 42.8%, and 28.6% each for 2+ and 4+. Low grade positivity (0–1+) in CK15 staining was present in 52.1% of nodular BCC, 46.2% – nodular/infiltrative, 92.3% – infiltrative, and 100% – BSC, but levels 2–3+ in nodular BCC in 47.8%, nodular/infiltrative BCC – 53.8%, infiltrative – 7.7%. Bcl-2 positivity (3–4+) was revealed in nodular BCC in 95.6%, (1–2+) in 100% of BSC, infiltrative and infiltrative/nodular BCC, but the lowest (0–1+) in 76.9% of nodular/infiltrative BCC, 71.4% of BSC, and in 38.4% of infiltrative BCC.

Conclusions
Positive Bmi-1 staining was the highest in the aggressive infiltrative subtype of BCCs, whereas the lowest in basosquamous cell carcinomas (BSC). Infiltrative BCC was characterized by a lower level of CK15 expression than nodular BCC and nodular/infiltrative BCC. Differentiation of Bcl-2 expression depended on the type of tumour; the highest level was found in nodular BCC, low grade in nodular/infiltrative and infiltrative BCCs, and BSC.

keywords:

basal cell carcinoma, immunohistochemical markers expression

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.